Cover Image

Bioequivalence study of low dose drospirenone/ethinyl estradiol 3 mg/0.03 mg film tablets under fasting conditions in Turkish healthy female subjects

Abstract This bioequivalence research aims to evaluate the relative bioavailability and pharmacokinetic characteristics of ethinyl estradiol and drospirenone in the test preparation in comparison to the reference preparation during fasting conditions. A liquid chromatography method with tandem mass...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ahmet Inal (Author), Zafer Sezer (Author), Berna Uluözlü (Author), Melih Oflas (Author), Martin Reinsch (Author), Wolfgang Martin (Author), Mümtaz M. Mazicioglu (Author), Selma Alime Koru (Author)
Format:	Book
Published:	Wiley, 2024-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Dysmenorrhea: effectiveness and acceptability of treatment with a drug containing 2 mg of chloromadinone acetate and 0.03 mg of ethinyl estradiol
by: V N Prilepskaia, et al.
Published: (2017)

Therapeutic non-contraceptive properties of the drug containing ethinylestradiol 0.03 mg and drospirenone 3 mg
by: Natalia V Artymuk, et al.
Published: (2019)

Efficacy and safety of combined ethinyl estradiol/drospirenone oral contraceptives in the treatment of acne
by: Jerry KL Tan, et al.
Published: (2009)

Efficacy and safety of drospirenone 2 mg/17β-estradiol 1 mg hormone therapy in Korean postmenopausal women
by: Bo Ra Park, et al.
Published: (2024)

Simultaneous determination of ethinyl estradiol and drospirenone in oral contraceptive by high performance liquid chromatography
by: Viviane Benevenuti Silva, et al.
Published: (2013)

Simultaneous total occlusion of two coronary arteries associated with use of drospirenone-ethinyl estradiol (oral contraceptive)
by: Hüsnü Atmaca, et al.
Published: (2018)

Safety, efficacy, actions, and patient acceptability of drospirenone/ethinyl estradiol contraceptive pills in the treatment of premenstrual dysphoric disorder
by: Lesley L Breech, et al.
Published: (2009)

Effectiveness and safety assessment of drospirenone/ethinyl estradiol tablet in treatment of PCOS patients: a single center, prospective, observational study
by: Li Li, et al.
Published: (2020)

The lowest-dose, extended-cycle combined oral contraceptive pill with continuous ethinyl estradiol in the United States: a review of the literature on ethinyl estradiol 20 µg/levonorgestrel 100 µg + ethinyl estradiol 10 µg
by: Sheila Krishnan, et al.
Published: (2010)

The New Extended-Cycle Levonorgestrel-Ethinyl Estradiol Oral Contraceptives
by: Rachel A. Bonnema, et al.
Published: (2011)

Cycle control with an extended-regimen oral contraceptive combining levonorgestrel and ethinyl estradiol that includes continuous low-dose ethinyl estradiol instead of the traditional hormone-free interval
by: Nappi RE, et al.
Published: (2017)

Efficacy, safety, and patient acceptability of the etonogestrel and ethinyl estradiol vaginal ring
by: Lete I, et al.
Published: (2014)

Bioequivalence Study of 100-mg Cilostazol Tablets in Healthy Thai Adult Volunteers
by: Somruedee Chatsiricharoenkul, MD, et al.
Published: (2019)

Comparative bioequivalence studies of tramadol hydrochloride sustained-release 200 mg tablets
by: Suhas S Khandave, et al.
Published: (2010)

Bioequivalence of bisoprolol, coated tablets 10 mg JSC «Chimpharm» Republic of Kazakhstan
by: Y. M. Budach, et al.
Published: (2013)

Information on the combined hormonal contraceptives (CHC) containing the dienogest + ethinyl estradiol combination (Jeanine®)
by: A. D. Makatsariya, et al.
Published: (2019)

Bleeding Pattern and Management of Unexpected Bleeding/Spotting with an Extended Regimen of a Combination of Ethinylestradiol 20 mcg and Drospirenone 3 mg
by: Bonassi Machado R, et al.
Published: (2020)

Evaluation of Bioequivalency and Pharmacokinetic Parameters for Two Formulations of Glimepiride 1-mg in Chinese Subjects
by: Ju G, et al.
Published: (2020)

Bioequivalence study of a new sildenafil 100 mg orodispersible film compared to the conventional film-coated 100 mg tablet administered to healthy male volunteers
by: Radicioni M, et al.
Published: (2017)

In vitro bioequivalence profile of Penicillin V tablets marketed in Kisangani, Democratic Republic of the Congo: Assay and dissolution kinetics of generic 250 mg and originator 600 mg
by: Rachel Ndezu Angirio, et al.
Published: (2024)

Impact of Ethinyl Estradiol to Human Telomerase Reverse Transcriptase Activity on Complete Hydatidiform Mole Culture
by: Tatit Nurseta, et al.
Published: (2016)

Unilateral Erythema Nodosum following Norethindrone Acetate, Ethinyl Estradiol, and Ferrous Fumarate Combination Therapy
by: Michelle S. Min, et al.
Published: (2016)

Evaluation of the potential for pharmacokinetic interaction between tirabrutinib and levonorgestrel/ethinyl estradiol in healthy female volunteers
by: Ganesh Cherala, et al.
Published: (2022)

Efficacy and cardiovascular safety of the new estrogen-free contraceptive pill containing 4 mg drospirenone alone in a 24/4 regime
by: Santiago Palacios, et al.
Published: (2020)

Study of the pharmacokinetic profile of the medicinal product Gidazepam®, tablets, 50 mg in a bioequivalence study
by: E. V. Baskakov, et al.
Published: (2023)

A comparative study of pharmacokinetics and bioequivalence of Cardiopril tablets 20 mg (JSC «Himfarm», Kazakhstan) and Monopril® tablets of 20 mg («Bristol-Myers Squibb SRL», Italy)
by: A. K. Sariev, et al.
Published: (2014)

Evaluation of the bioequivalence of two formulations containing the combination of 400 mg of acetaminophen (paracetamol), 4 mg of phenylephrine and 4 mg of chlorpheniramine in capsules: open-label, three-way crossover study, partially replicated in healthy volunteers of both sexes
by: Alessandra Ferreira dos Santos, et al.
Published: (2020)

New low-dose, extended-cycle pills with levonorgestrel and ethinyl estradiol: an evolutionary step in birth control
by: Anita Nelson
Published: (2010)

Effects of the selective AMPA modulator NBI‐1065845 on the pharmacokinetics of midazolam or ethinyl estradiol-levonorgestrel in healthy adults
by: Swan Lin, et al.
Published: (2024)

High-sensitivity simultaneous liquid chromatographyâtandem mass spectrometry assay of ethinyl estradiol and levonorgestrel in human plasma
by: Abhishek Gandhi, et al.
Published: (2015)

Evaluation of the food effect on a drospirenone only contraceptive containing 4 mg administered with and without high-fat breakfast in a randomised trial
by: P.-A. Regidor, et al.
Published: (2022)

Bioequivalence Study Of A Fixed-Dose Combination Tablet Containing Melitracen 10 mg And Flupentixol 0.5 mg In Healthy Chinese Volunteers Under Fasted And Fed Conditions
by: Wu L, et al.
Published: (2019)

Bioequivalence studies Nipezam retard tablets, 400 mg (JSC «Himfarm», Kazakhstan) and Finlepsin® 400 retard tablets 400 mg («Pliva Krakow, SA Pharmaceutical company», Poland)
by: A. K. Sariev, et al.
Published: (2014)

Quality of Life in Japanese Patients with Dysmenorrhea Treated with Ethinylestradiol 20 μg/Drospirenone 3 mg in a Real-World Setting: An Observational Study
by: Momoeda M, et al.
Published: (2020)

A Randomized, Two-Treatments, Two-Periods, Crossover, Open label, Laboratory-Blind, Single Dose Bioequivalence Study between Vildagliptin/Metformin 50 mg/1000 mg Film Coated Tablets (Sensityn®) and Galvusmet® 50 mg/1000 mg Film Coated Tablets in healthy adults under fed conditions
by: Shiekmydeen J., et al.
Published: (2023)

The efficacy of 17β-estradiol and low dosed drospirenone use in postmenopausal women (literature review)
by: E N Andreeva, et al.
Published: (2015)

Bioequivalence study of abacavir/lamivudine (600/300-mg) tablets in healthy Thai volunteers under fasting conditions
by: Ekawan Yoosakul, et al.
Published: (2016)

A Comparative Pharmacokinetic Study of Fexuprazan 10 mg: Demonstrating Bioequivalence with the Reference Formulation and Evaluating Steady State
by: Wonsuk Shin, et al.
Published: (2023)

Comparative bioequivalence study of Pioglitazone tablets, 20 mg (JSC «Chimpharm», Kazakhstan) and Actos® Tablets, 30 mg («Eli Lilly Holdings, Takeda Global Research and Development Centre Europe Ltd»)
by: A. K. Sariev, et al.
Published: (2013)

Evaluación de la potencia hormonal del anticonceptivo inyectable mensual de Dihidroxiprogesterona acetofenido 150 mg y estradiol enantato 10 mg, comparativamente con tratamientos anticonceptivos orales
by: Luz Amparo Montoya de Toro, et al.
Published: (1992)